K. M. Baldwin
YOU?
Author Swipe
View article: <scp>HLA</scp>class<scp>II</scp>diversity in<scp>HIV</scp>‐1 uninfected individuals from the placebo arm of the<scp>RV144</scp>Thai vaccine efficacy trial
<span>HLA</span>class<span>II</span>diversity in<span>HIV</span>‐1 uninfected individuals from the placebo arm of the<span>RV144</span>Thai vaccine efficacy trial Open
The RV144 HIV vaccine trial in Thailand elicited antibody responses to the envelope of HIV ‐1, which correlated significantly with the risk of HIV ‐1 acquisition. Human leukocyte antigen ( HLA ) class II molecules are essential in antigen …